Family Medicine · San Dimas, CA
NPI
1306836770
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
6
Hospital affiliations
1334 W Covina Blvd, Ste 204
San Dimas, CA, 91773
Phone (909) 599-6300
Medicare paid, 2024
$758K
12,484 services
Medicare patients, 2024
729
Average age 70
Drug cost, 2024
$2.4M
29,075 prescriptions
Company payments, 2025
$736
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sabah Kadhium was code 99308 (snf e&m), 6,071 times for 253 patients. In total Sabah Kadhium billed 12,484 services in 31 codes, and Medicare paid $758K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Facility | 6,071 | 253 | $56.20 | $341K |
| 99232 Hospital E&M - Subsequent | Facility | 2,021 | 284 | $59.00 | $119K |
| 99213 Office E&M - Established | Office | 988 | 201 | $61.56 | $61K |
| 99214 Office E&M - Established | Office | 631 | 212 | $85.15 | $54K |
| 99233 Hospital E&M - Subsequent | Facility | 628 | 128 | $88.68 | $56K |
| 96372 Injection Administration | Office | 405 | 128 | $10.13 | $4,101 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 384 | 125 | $0.88 | $336 |
| 99223 Hospital E&M - Initial | Facility | 345 | 229 | $129.08 | $45K |
| 99306 SNF E&M | Facility | 322 | 182 | $137.49 | $44K |
| 82962 Clinical Chemistry | Office | 142 | 55 | $3.21 | $456 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 139 | 139 | $127.57 | $18K |
| 99238 Hospital Discharge Management | Facility | 132 | 101 | $61.42 | $8,107 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Facility | 85 | 32 | $31.29 | $2,660 |
| 97032 PT Treatment | Office | 49 | 21 | $10.47 | $513 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 42 | 36 | $41.45 | $1,741 |
By year: 2022 $755K for 13,154 services; 2023 $703K for 11,639 services; 2024 $758K for 12,484 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 142 | 55 | $3.21 | $456 |
Medicare prescription drug claims, 2024
In 2024, the drug Sabah Kadhium prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,163 prescriptions and refills. In total Sabah Kadhium wrote 29,075 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,163 | 1,745 | 202 | $12K |
| Amlodipine Besylate Generic | 805 | 1,220 | 136 | $5,262 |
| Eliquis Apixaban | 724 | 789 | 75 | $259K |
| Gabapentin Generic | 713 | 859 | 108 | $11K |
| Losartan Potassium Generic | 693 | 1,243 | 136 | $6,649 |
| Levothyroxine Sodium Generic | 622 | 1,006 | 96 | $7,384 |
| Famotidine Generic | 604 | 783 | 86 | $7,534 |
| Pantoprazole Sodium Generic | 577 | 831 | 115 | $18K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 574 | 575 | 89 | $18K |
| Metoprolol Tartrate Generic | 563 | 747 | 74 | $3,977 |
| Carvedilol Generic | 517 | 777 | 78 | $4,235 |
| Donepezil Hcl Generic | 451 | 566 | 62 | $4,446 |
| Memantine Hcl Generic | 446 | 472 | 43 | $12K |
| Tamsulosin Hcl Generic | 446 | 727 | 87 | $6,174 |
| Lisinopril Generic | 429 | 748 | 79 | $3,071 |
Brand drugs: 4,251 claims; generic drugs: 24,640 claims; opioid claims: 1,304.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sabah Kadhium $736 ($736 in general payments such as food, travel and fees) from 11 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $198.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 8 | $198 |
| Novo Nordisk Inc NVO | 3 | $85.43 |
| Lundbeck LLC | 3 | $75.7 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $75.14 |
| Lilly USA, LLC LLY | 3 | $73.7 |
| Kowa Pharmaceuticals America, Inc. | 3 | $64.12 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50.1 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $41.98 |
| Pfizer Inc. PFE | 1 | $27.2 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $23.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.